Dr. Anna Margolina, PhD
Biography & Research Background
Anna Margolina, PhD, worked in the Research & Development Department of Skin Biology, Inc. A long-time collaborator with Dr. Pickart, she was instrumental in analyzing GHK's effects on gene expression. Her research focuses on GHK's potential to reverse epigenetic changes associated with aging, cancer metastasis, and COPD. Key publications: 'GHK-Cu may Prevent Oxidative Stress in Skin' (2015, Cosmetics), 'GHK and DNA: Resetting the Human Genome to Health' (2014), 'The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging' (2012). Anna Margolina is referenced as a key scientist in GHK-Cu research. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Anna Margolina, PhD is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Anna Margolina, PhD is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.